Ryoichi Ando

787 total citations
29 papers, 461 citations indexed

About

Ryoichi Ando is a scholar working on Organic Chemistry, Molecular Biology and Nephrology. According to data from OpenAlex, Ryoichi Ando has authored 29 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Nephrology. Recurrent topics in Ryoichi Ando's work include Parathyroid Disorders and Treatments (4 papers), Cyclopropane Reaction Mechanisms (3 papers) and Synthetic Organic Chemistry Methods (3 papers). Ryoichi Ando is often cited by papers focused on Parathyroid Disorders and Treatments (4 papers), Cyclopropane Reaction Mechanisms (3 papers) and Synthetic Organic Chemistry Methods (3 papers). Ryoichi Ando collaborates with scholars based in Japan, China and United States. Ryoichi Ando's co-authors include Isao Kuwajima, Makoto Shimizu, Masahiko Isaka, Hidetoshi Tokuyama, Shotaro Naito, Naho Kobayashi, Satoko Hanada, S. Sasaki, Masashi Wakabayashi and Sei Sasaki and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Ryoichi Ando

27 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryoichi Ando Japan 14 167 124 96 76 46 29 461
Ting Zhu China 16 126 0.8× 348 2.8× 36 0.4× 88 1.2× 38 0.8× 44 731
Jothilingam Sivapackiam United States 13 255 1.5× 115 0.9× 14 0.1× 48 0.6× 12 0.3× 26 536
Guo‐Yuan Lu China 15 113 0.7× 253 2.0× 36 0.4× 54 0.7× 15 0.3× 28 621
Steven C. Zammit Australia 13 291 1.7× 153 1.2× 32 0.3× 42 0.6× 15 0.3× 14 481
JoLyn Turner United States 7 42 0.3× 116 0.9× 114 1.2× 111 1.5× 27 0.6× 9 390
J. Stuart Woodhead United Kingdom 11 80 0.5× 311 2.5× 163 1.7× 104 1.4× 41 0.9× 23 692
Andrew M. K. Pennell United Kingdom 11 368 2.2× 145 1.2× 30 0.3× 93 1.2× 9 0.2× 12 613
Yutaka Nakajima Japan 13 90 0.5× 117 0.9× 42 0.4× 98 1.3× 41 0.9× 34 437
Lulu Li China 14 57 0.3× 382 3.1× 40 0.4× 73 1.0× 61 1.3× 22 565
Chiara Rusconi Italy 15 78 0.5× 123 1.0× 27 0.3× 182 2.4× 43 0.9× 53 563

Countries citing papers authored by Ryoichi Ando

Since Specialization
Citations

This map shows the geographic impact of Ryoichi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoichi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoichi Ando more than expected).

Fields of papers citing papers by Ryoichi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoichi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoichi Ando. The network helps show where Ryoichi Ando may publish in the future.

Co-authorship network of co-authors of Ryoichi Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoichi Ando. A scholar is included among the top collaborators of Ryoichi Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoichi Ando. Ryoichi Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kikuchi, Kan, Masaomi Nangaku, Munekazu Ryuzaki, et al.. (2023). Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID‐19 in clinical practice during the Omicron (BA.1 and BA.2) pandemic. Therapeutic Apheresis and Dialysis. 27(6). 1064–1069. 4 indexed citations
2.
Kikuchi, Kan, Masaomi Nangaku, Munekazu Ryuzaki, et al.. (2021). Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study. Renal Replacement Therapy. 7(1). 59–59. 30 indexed citations
3.
Ando, Ryoichi, et al.. (2017). Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome. CEN Case Reports. 6(1). 105–110. 17 indexed citations
4.
Arai, Yohei, Eiichiro Kanda, Soichiro Iimori, et al.. (2016). The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4–5: the CKD-ROUTE study. Clinical and Experimental Nephrology. 21(3). 481–487. 8 indexed citations
5.
Ando, Ryoichi. (2016). . Nihon Toseki Igakkai Zasshi. 49(11). 727–731.
6.
Ando, Ryoichi. (2015). . Nihon Toseki Igakkai Zasshi. 48(11). 683–690. 6 indexed citations
7.
Fukunaga, Kenji, Kazutoshi Watanabe, Ryoichi Ando, et al.. (2013). 6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6928–6932. 24 indexed citations
8.
Ando, Ryoichi, Hiroshi Ikegami, Masayuki Hayashi, et al.. (2010). 3-Cyano-6-(5-methyl-3-pyrazoloamino)pyridines: Selective Aurora A kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(15). 4709–4711. 23 indexed citations
9.
Hanada, Satoko, Ryoichi Ando, Shotaro Naito, et al.. (2010). Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrology Dialysis Transplantation. 25(6). 1888–1895. 52 indexed citations
10.
Iwamoto, Mari, et al.. (2009). Calcium-Alkali Syndrome Due to Vitamin D Administration and Magnesium Oxide Administration. American Journal of Kidney Diseases. 53(4). 711–714. 14 indexed citations
11.
Ando, Ryoichi, et al.. (2007). 2-tert-Butoxy-3-phenylcyclopropanone acetal, a stable precursor of lithiated 2-phenylcyclopropenone acetal. Tetrahedron Letters. 48(39). 7011–7014. 2 indexed citations
12.
Ando, Ryoichi, et al.. (2006). Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents. Bioorganic & Medicinal Chemistry Letters. 16(12). 3315–3318. 11 indexed citations
13.
Ando, Ryoichi, et al.. (2006). A Concise Total Synthesis of 7-Substituted Eudistomin Analogs. Letters in Organic Chemistry. 3(6). 455–458. 6 indexed citations
14.
Ando, Ryoichi. (1999). Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities. Bioorganic & Medicinal Chemistry. 7(4). 571–579. 30 indexed citations
15.
Ando, Ryoichi, et al.. (1993). A new class of proteinase inhibitor. Cyclopropenone-containing inhibitor of papain. Journal of the American Chemical Society. 115(3). 1174–1175. 27 indexed citations
16.
Tokuyama, Hidetoshi, et al.. (1992). Synthesis and biological activities of cyclopropenone antibiotic penitricin and congeners.. The Journal of Antibiotics. 45(7). 1148–1154. 18 indexed citations
17.
Isaka, Masahiko, et al.. (1991). One-pot synthesis of substituted cyclopropenone ketals via alkylation of 3,3-dialkoxy-2-sodiocyclopropenes. Tetrahedron Letters. 32(10). 1339–1342. 10 indexed citations
18.
Uchida, Shinichi, Osamu Matsuda, Takanori Yokota, et al.. (1990). Adult Fanconi Syndrome Secondary to ĸ-Light Chain Myeloma: Improvement of Tubular Functions after Treatment for Myeloma. ˜The œNephron journals/Nephron journals. 55(3). 332–335. 15 indexed citations
19.
Ando, Ryoichi, et al.. (1983). Reactions of active methyne compounds with vinyl selenones. One-step synthesis of 2-acylcyclopropanecarbaldehydes. Journal of the Chemical Society Chemical Communications. 1514–1514. 9 indexed citations
20.
Shimizu, Makoto, Ryoichi Ando, & Isao Kuwajima. (1981). Highly efficient method for ethylenic or acetylenic ketones via fragmentation of hydroxy vinyl selenones. The Journal of Organic Chemistry. 46(25). 5246–5248. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting Zhu Breakdown of academic impact, for papers by Jothilingam Sivapackiam Breakdown of academic impact, for papers by Guo‐Yuan Lu Breakdown of academic impact, for papers by Steven C. Zammit Breakdown of academic impact, for papers by JoLyn Turner Breakdown of academic impact, for papers by J. Stuart Woodhead Breakdown of academic impact, for papers by Andrew M. K. Pennell Breakdown of academic impact, for papers by Yutaka Nakajima Breakdown of academic impact, for papers by Lulu Li Breakdown of academic impact, for papers by Chiara Rusconi
Rankless by CCL
2026